心臓バイオマーカーの世界市場:種類別(筋肉型クレアチンキナーゼ、ミオグロビン、トロポニン(TおよびI)、虚血修飾アルブミン(IMA)、脳ナトリウム利尿ペプチド(BNP)/NT-proBNP、その他)、用途別(心筋梗塞、うっ血性心不全、急性冠症候群、アテローム性動脈硬化症、その他)、検査の場所別(臨床現場即時検査、臨床検査)、地域別予測

◆英語タイトル:Global Cardiac Biomarkers Market Size study, by type (Myocardial muscle Creatine Kinase, Myoglobin, Troponins (T and I), Ischemia Modified Albumin (IMA), Brain Natriuretic Peptide (BNPs) or NT-proBNP and Others) Application (myocardial infarction, congestive heart failure, acute coronary syndrome, Atherosclerosis, other applications) Location of Testing (point of care testing and laboratory testing) and Regional Forecasts 2018-2025.
◆商品コード:BZW9MR079
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2019年3月14日
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD3,950 ⇒換算¥434,500見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD5,550 ⇒換算¥610,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本資料は、心臓バイオマーカーの世界市場について調べ、心臓バイオマーカーの世界規模、市場動向、市場環境、種類別(筋肉型クレアチンキナーゼ、ミオグロビン、トロポニン(TおよびI)、虚血修飾アルブミン(IMA)、脳ナトリウム利尿ペプチド(BNP)/NT-proBNP、その他)分析、用途別(心筋梗塞、うっ血性心不全、急性冠症候群、アテローム性動脈硬化症、その他)分析、検査の場所別(臨床現場即時検査、臨床検査)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。業界の主要なプレイヤーはRoche Diagnostics、 Abbott Laboratories, 、Siemens Healthcare, 、Alere Inc., 、Becton, Dickinson and Company, 、Bio-Rad Laboratories, 、BioMerieux, 、Randox laboratories, 、Beckman Coulter 、 Thermo Fisher Scientific. などです。
・イントロダクション
・エグゼクティブサマリー
・心臓バイオマーカーの世界市場概要
・心臓バイオマーカーの世界市場環境
・心臓バイオマーカーの世界市場動向
・心臓バイオマーカーの世界市場規模
・心臓バイオマーカーの世界市場規模:種類別(筋肉型クレアチンキナーゼ、ミオグロビン、トロポニン(TおよびI)、虚血修飾アルブミン(IMA)、脳ナトリウム利尿ペプチド(BNP)/NT-proBNP、その他)
・心臓バイオマーカーの世界市場規模:用途別(心筋梗塞、うっ血性心不全、急性冠症候群、アテローム性動脈硬化症、その他)
・心臓バイオマーカーの世界市場規模:検査の場所別(臨床現場即時検査、臨床検査)
・心臓バイオマーカーの世界市場:地域別市場規模・分析
・心臓バイオマーカーの北米市場規模・予測
・心臓バイオマーカーのアメリカ市場規模・予測
・心臓バイオマーカーのヨーロッパ市場規模・予測
・心臓バイオマーカーのアジア市場規模・予測
・心臓バイオマーカーの日本市場規模・予測
・心臓バイオマーカーの中国市場規模・予測
・関連企業情報
【レポートの概要】

Global cardiac biomarkers market to reach USD 4,957.1 million by 2025.

Global cardiac biomarkers market is valued at approximately USD 1,241 million in 2017 and is anticipated to grow with a healthy growth rate of more than 18.9 % over the forecast period 2018-2025. Rising prevalence of cardiovascular diseases cost effective device, non-invasive method, accuracy in prediction, helpful in clinical trials, multi-application, increasing point of care application along with the technological advancements using cardiac biomarkers are some key trends that are responsible for the wide adoption of cardiac biomarkers globally.

Global cardiac biomarker market is majorly driven by rising prevalence of cardiovascular diseases. Cardiovascular diseases such as circulatory diseases, heart attacks and strokes are the leading cause for the premature death across the world. Cardiovascular diseases are caused by rising stress level and work pressure, harmful use of alcohol, unhealthy diet, obesity, tobacco use, and physical inactivity and it is most popular in aging population. Thus, cardiovascular diseases are the major cause of death across the globe. According the World Health Organization (WHO), in 2015 around 17.7million people died from cardiovascular diseases, signifying 31 % of global deaths, out of these 7.4million died due to coronary heart disease and 6.7 million died due to stroke across the world. As a result, the demand & adoption of cardiac biomarker would increase thereby, aiding the growth of the market over the forecast period of 2018-2025. Key market challenge for the global cardiac biomarker market is approval clinical validity and utility of biomarkers- based tests. However, to overcome this challenge the market also has various opportunities such as point of care testing using cardiac biomarkers, future developments in novel cardiac biomarkers and demand of personalized medicine.
On the basis of segmentation, the cardiac biomarkers market is segmented into type, application and location of testing. The type segment of global Cardiac Biomarkers market is classified into creatine Kinase (CK-MB), Troponins (T.I), myoglobin, Natriuretic Peptides (BNP & NT-PROBNP), ischemia modified albumin, others. Based on application segment the global cardiac biomarkers market is classified into myocardial infarction, congestive heart failure, acute coronary syndrome, Atherosclerosis, other applications of which myocardial infarction holds the highest share in the global cardiac biomarkers market due to high prevalence of cardiovascular diseases. The location of testing segment includes point of care testing and laboratory testing of which point of care accounts for the fastest growing segment due to clinicians and doctors mainly use point of care cardiac testing for quick testing and monitoring patients who are having chest pain.

The regional analysis of cardiac biomarkers market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America and ROW. North America have occupied major share in the global cardiac biomarkers market. The major reasons for the dominance of North America are high CVD prevalence rates, high demand for cardiac testing and rising awareness towards cardiac diagnostics solutions. Whereas, Asia-Pacific is expected to emerge as the fastest growing region in terms of market share. The growth of Asia-Pacific region is witnessed owing to rising affordability for the advanced cardiac treatments, modernization in the countries and increasing disposable income.
The leading market players include-

 Roche Diagnostics
 Abbott Laboratories,
 Siemens Healthcare,
 Alere Inc.,
 Becton, Dickinson and Company,
 Bio-Rad Laboratories,
 BioMerieux,
 Randox laboratories,
 Beckman Coulter
 Thermo Fisher Scientific

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
 Myocardial muscle Creatine Kinase (CK-MB)
 Myoglobin
 Troponins (T and I)
 Ischemia Modified Albumin (IMA)
 Brain Natriuretic Peptide (BNPs) or NT-proBNP
 Others
By Application:
 Congestive Heart Failure
 Myocardial Infarction
 Atherosclerosis
 Acute Coronary Syndrome
 Others
By Location of testing:
 Laboratory testing
 Point of care testing
By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
o ROE
 Asia Pacific
o China
o India
o Japan
o ROAPEC
 LAMEA
o Brazil
o Mexico
 ROW
o Middle East & Africa

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025

Target Audience of the Global Cardiac Biomarkers Market in Market Study:

 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors

【レポートの目次】

TABLE OF CONTENTS
Chapter 1. Global Cardiac Biomarkers Market Definition and Scope
1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation
Chapter 2. Research Methodology
2.1. Research Process
2.1.1. Data Mining
2.1.2. Analysis
2.1.3. Market Estimation
2.1.4. Validation
2.1.5. Publishing
2.2. Research Assumption
Chapter 3. Executive Summary
3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends
Chapter 4. Global Cardiac Biomarkers Market Dynamics
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
Chapter 5. Global Cardiac Biomarkers Market, By Type
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Global Cardiac Biomarkers Market, Sub Segment Analysis
5.3.1. Myocardial muscle Creatine Kinase (CK-MB)
5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.2. Myoglobin
5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.3. Troponins (T and I)
5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.4. Ischemia Modified Albumin (IMA)
5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.5. Brain Natriuretic Peptide (BNPs) or NT-proBNP
5.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.6. Others
5.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 6. Global Cardiac Biomarkers Market, By Application
6.1. Market Snapshot
6.2. Market Performance – Potential Model
6.3. Global Cardiac Biomarkers Market, Sub Segment Analysis
6.3.1. Congestive Heart Failure
6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.2. Myocardial Infarction
6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.3. Atherosclerosis
6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.4. Acute Coronary Syndrome
6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.5. Others
6.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 7. Global Cardiac Biomarkers Market, By Location Testing
7.1. Market Snapshot
7.2. Market Performance – Potential Model
7.3. Global Cardiac Biomarkers Market, Sub Segment Analysis
7.3.1. Laboratory testing
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2. Point of care testing
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Global Cardiac Biomarkers Market, by Regional Analysis
8.1. Cardiac Biomarkers Market, Regional Market Snapshot (2015-2025)
8.2. North America Cardiac Biomarkers Market Snapshot
8.2.1. U.S.
8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2. Canada
8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3. Europe Cardiac Biomarkers Market Snapshot
8.3.1. U.K.
8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2. Germany
8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3. Rest of Europe
8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4. Asia Cardiac Biomarkers Market Snapshot
8.4.1. China
8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2. India
8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3. Japan
8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4. Rest of Asia Pacific
8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5. Latin America Cardiac Biomarkers Market Snapshot
8.5.1. Brazil
8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2. Mexico
8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6. Rest of The World
8.6.1. Middle East and Africa
8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.4. Location of testing breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 9. Competitive Intelligence
9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Roche Diagnostics
9.3.1.1. Overview
9.3.1.2. Financial (Subject to Data Availability)
9.3.1.3. Product Summary
9.3.1.4. Recent Developments
9.3.2. Abbott Laboratories,
9.3.3. Siemens Healthcare,
9.3.4. Alere Inc.,
9.3.5. Becton, Dickinson and Company,
9.3.6. Bio-Rad Laboratories,
9.3.7. BioMerieux,
9.3.8. Randox laboratories,
9.3.9. Beckman Coulter
9.3.10. Thermo Fisher Scientific.

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CARDIAC BIOMARKERS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CARDIAC BIOMARKERS MARKET
TABLE 3. GLOBAL CARDIAC BIOMARKERS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
TABLE 7. GLOBAL CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
TABLE 8. GLOBAL CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY APPLICATION 2015-2025 (USD BILLION)
TABLE 9. GLOBAL CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY LOCATION OF TESTING 2015-2025 (USD BILLION)
TABLE 10. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 11. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 12. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 13. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 14. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 15. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 16. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 17. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 18. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 19. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 20. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 21. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 22. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 23. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 24. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 25. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 26. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 27. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 28. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 29. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 30. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 31. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 32. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 33. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 34. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 35. GLOBAL CARDIAC BIOMARKERS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 36. U.S. CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 37. U.S CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 38. U.S CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 39. U.S CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 40. CANADA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 41. CANADA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 42. CANADA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 43. CANADA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 44. UK CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 45. UK CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 46. UK CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 47. UK CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 48. GERMANY CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 49. GERMANY CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 50. GERMANY CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 51. GERMANY CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 52. ROE CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 53. ROE CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 54. ROE CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 55. ROE CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 56. CHINA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 57. CHINA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 58. CHINA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 59. CHINA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 60. INDIA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 61. INDIA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 62. INDIA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 63. INDIA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 64. JAPAN CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 65. JAPAN CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 66. JAPAN CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 67. JAPAN CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 68. ROAPAC CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 69. ROAPEC CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 70. ROAPEC CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 71. ROAPEC CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 72. BRAZIL CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 73. BRAZIL CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 74. BRAZIL CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 75. BRAZIL CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 76. MEXICO CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 77. MEXICO CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 78. MEXICO CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 79. MEXICO CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 80. MIDDLE EAST & AFRICA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 81. MIDDLE EAST & AFRICA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 82. MIDDLE EAST & AFRICA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 83. MIDDLE EAST & AFRICA CARDIAC BIOMARKERS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

FIG 1. GLOBAL CARDIAC BIOMARKERS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL CARDIAC BIOMARKERS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL CARDIAC BIOMARKERS MARKET, KEY TRENDS 2016
FIG 5. GLOBAL HEAT EXCHANGERS, GROWTH PROSPECTS 2017-2025
FIG 6. GLOBAL CARDIAC BIOMARKERS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL CARDIAC BIOMARKERS MARKET, PEST ANALYSIS
FIG 8. GLOBAL CARDIAC BIOMARKERS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 10. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 11. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 12. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 13. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 14. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 15. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 16. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 17. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 18. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 19. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 20. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 21. GLOBAL CARDIAC BIOMARKERS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 22. GLOBAL CARDIAC BIOMARKERS MARKET, REGIONAL SNAPSHOT 2015 & 2025
FIG 23. NORTH AMERICA CARDIAC BIOMARKERS MARKET 2015 & 2025 (USD BILLION)
FIG 24. EUROPE CARDIAC BIOMARKERS MARKET 2015 & 2025 (USD BILLION)
FIG 25. ASIA PACIFIC CARDIAC BIOMARKERS MARKET 2015 & 2025 (USD BILLION)
FIG 26. LATIN AMERICA CARDIAC BIOMARKERS MARKET 2015 & 2025 (USD BILLION)
FIG 27. ROW CARDIAC BIOMARKERS MARKET 2015 & 2025 (USD BILLION)
FIG 28. GLOBAL CARDIAC BIOMARKERS MARKET, COMPANY MARKET SHARE ANALYSIS (2016)

【掲載企業】

Roche Diagnostics、 Abbott Laboratories, 、Siemens Healthcare, 、Alere Inc., 、Becton, Dickinson and Company, 、Bio-Rad Laboratories, 、BioMerieux, 、Randox laboratories, 、Beckman Coulter 、 Thermo Fisher Scientific.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[心臓バイオマーカーの世界市場:種類別(筋肉型クレアチンキナーゼ、ミオグロビン、トロポニン(TおよびI)、虚血修飾アルブミン(IMA)、脳ナトリウム利尿ペプチド(BNP)/NT-proBNP、その他)、用途別(心筋梗塞、うっ血性心不全、急性冠症候群、アテローム性動脈硬化症、その他)、検査の場所別(臨床現場即時検査、臨床検査)、地域別予測]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆